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Rat pancreatlcp cells exhibit a 16-fold higher glutamate decarboxylase (GAD) activity than islet non-/I cells. but a similar glutamate dehydrogenase 
(GDH) activity. B Cells which survive exposure to 2 mM streptozotocin only contain 10 percent of the GAD activity of control cells, but their 
GDH activity remams unaltered. Culture of streptozotocm-treated p cell preparations with 2 mM mcotinamide reduces the number of dead cells 
and prevents in part the decline in GAD activity of survlvmg p cells. These data indicate that loss m activity of the p cell specdic enzyme GAD 
can serve as marker fora cells which survived a destructive process. It is furthermore demonstrated that mcotmarmde increases the percent survlvmg 
cells and decreases their loss in GAD activity. 
B Cell: Diabetes: Autoantibody: Streptozotocm; Islet, Glutamate decarbocylase 
1. INTRODUCTION purpose of comparing enzyme activities m freshly isolated islet p and 
islet non-p cells. 
In man, development of insulin-dependent diabetes is 
often associated with the appearance of circulating anti- 
bodies that recognize antigens in pancreaticp cells [l-3]. 
Glutamate decarboxylase (GAD) has been identified as 
one of the p cell antigens to which autoantibodies are 
produced during the preclinical phase of the disease 
[4,5]. It is unknown whether and, if so, how the forma- 
tion of GAD-antibodies is related to the destruction of 
p cells which occurs during this period. Autoantibodies 
often disappear during the clinical course of the disease, 
which has been interpreted as a sign of a depleted /? cell 
mass and vanishing autoantigens [6]. They may also be 
present in genetically susceptible individuals who are 
unlikely to develop the disease [7]. In the present study, 
we used the cellular GAD-activity to examine the course 
of the enzyme following in vitro damage to rat islet /3 
cells. 
2. MATERIALS AND METHODS 
2.1. Preporatwn of rat /I cells 
Islet p cells were prepared from adult male Wistar rats (150-250 g 
body weight) according to previously described techmques [S]. Briefly, 
Islets were isolated after collagenase digestion ofthe pancreas and then 
dissociated into a cell suspension by treatment with trypsm m a cal- 
clum-free medium [8]. SmgleP cells were purified by autofluorescence- 
activated sorting of the dispersed cells [8]. In 3 experiments. the pop- 
ulation of islet endocrine non-/? cells was also Isolated [8] with the 
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2.1. Culture cond~tlons and esposwe to strepto:otocm 
Purified p cells were suspended m Ham’s FlO medium at 10 mM 
glucose, supplemented with 2 mM L-glutamine. 50 PM 3’-isobutyl-l- 
methylxantm, penicillin (0.075 mg/ml) and streptomycin (0.1 ng/ml). 
and then reaggregated during a 3 h rotary shaking incubation at 37°C 
[9] The aggregates were subsequently cultured under static conditions 
for a total period of 9 to 10 days. Every other day. half of the medium 
volume was replaced by fresh medium. After 7 or 8 days of culture, 
the cells were distributed over Lux dishes containmg 3 ml of the same 
culture medmm (6.105 cells at start per dish). After 2 h of culture m 
the Lux dishes, streptozotocm (final cont. 2 mM) or only its solvent 
(1 mM HCI) was added. Streptozotocin exposure lasted 30 mm after 
which drug-treated and control cells were extensively washed and 
further cultured for 48 hours m the above culture medium with or 
wlthout 2 mM mcotmamide. At the end of this period the medium was 
recovered for insulin assay and the cells evtenslvely washed before 
sampling for assays 
Before and after culture. cells were analysed for their msuhn and 
DNA content [8] as well as for their glutamate decarboxylase and 
glutamate dehydrogenase activities [lO,l I]. Hormone content and en- 
zymatic actlvitles are expressed per ng DNA that was measured in the 
same cell preparation. Results are presented as mean values * S.E.M. 
and significance of differences calculated by Student‘s t-test 
3. RESULTS 
3.1. Glutantatr decarhoxylase actiritl* in rat islet p cells 
Freshly purified rat j? cells contain a glutamate decar- 
boxylase (GAD) activity (50?6 fmol/min/ng DNA) 
which is 16-fold higher than that of freshly isolated islet 
non-p cells (3 fmol/min/ng DNA). A 9 to 10 day culture 
period at 10 mM glucose does not result in significant 
alterations of GAD-activity in p cells (37 & 9 fmol/min/ 
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ng DNA, p > 0.05). On the other hand, glutamate dehy- 
drogenase (GDH) exhibits comparable activities in islet 
/3 cells (4.0 ? 0.2 pmol/min/ng DNA) and islet non-p 
cells (4.4 pmol/min/ng DNA). As for GAD, GDH-ac- 
tivity is comparable in freshly isolated and cultured p 
cells (3.8 & 0.6 pmol/min/ng DNA, P > 0.05). 
3.2. Effect of streptozotocin on /3 cell survival 
Comparison of the DNA content in the control prep- 
aration before and after culture indicated that the 9 to 
10 day culture period resulted in a loss of 25 percent of 
the intial number of/? cells (5.7 f 0.4 ng DNA per 1000 
cells on day 1 was reduced on day 9 or 10, to 4.2 + 0.4 
ng DNA per 1000 cells at start P < 0.05). The effect of 
streptozotocin on p cell survival was evaluated by com- 
paring the DNA content of streptozotocin-treated prep- 
arations with that of paired cultured control cells. After 
30 min exposure to 2 mM streptozotocin and a subse- 
quent 48 h culture without the drug, cell recovery was 
53 percent lower than in the control condition as de- 
rived from the respective DNA contents. The presence 
of 2 mM nicotinamide in the post-streptozotocin culture 
period improved cell recovery (only 36 percent reduc- 
tion as compared to controls). When control prepara- 
tions were cultured with 2 mM nicotinamide during the 
final 48 hours, DNA recovery tended to be higher 
(5.2 ? 0.1 ng DNA per 1000 cells at start) than without 
this agent (4.2 + 0.4 ng DNA recovered per 1000 cells 
at start) but this difference was not statistically signifi- 
cant. 
3.3. Characteristics of cells surviving after strepto- 
zotocin exposure 
Cells surviving streptozotocin-treatment and subse- 
quent culture were compared to those recovered from 
control cultures by expressing the respective hormone 
contents and enzyme activities per ng recovered DNA 
(Table I). 
The cells recovered in the streptozotocin condition 
exhibited a similar hormone content (5.6 5 1.3 ng insu- 
lin/ng DNA) than control cells (3.8 f 0.7 ng insulin/ng 
DNA, p > 0.05); their incubation medium contained, 
however, significantly less hormone suggesting a reduc- 
tion in their secretory activity during the final 2 days of 
culture (Table I). Addition of nicotinamide to the cul- 
ture medium did not increase total hormone content per 
ng cellular DNA but raised the fraction that was re- 
leased in the medium both in control cells and in strep- 
tozotocin-treated cells (Table I). 
Streptozotocin-pretreated cells presented similar 
GDH activity as control cells, but their GAD-activity 
was only 7 percent of control values (Table I). The 
presence of nicotinamide in the culture medium did not 
alter cellular GDH activity but was found to partially 
protect against the decline in cellular GAD-activity of 
cells surviving streptozotocin treatment (Table I). 
4. DISCUSSION 
This study confirms that islet p cells contain gluta- 
mate decarboxylase and that the enzyme is /3 cell specific 
in rat islet tissue [ 12,131. A 10 day culture period did not 
alter GAD activity in rat p cells. Cultured p cells were 
used to examine whether exposure to a damaging agent 
such as streptozotocin alters GAD activity in p cells 
which have not been killed by the diabetogenic com- 
pound. The cells were incubated with streptozotocin for 
30 min. extensively washed to remove the drug and then 
cultured for 48 h at 10 mM glucose during which irre- 
versibly damaged cells detach from the aggregates and 
lose their viability; a second wash allows to remove dead 
cells as indicated by neutral red staining. Under the 
conditions used in this study, approximately 50 percent 
of the B cells were killed by the streptozotocin treat- 
ment. The remaining cells were neutral red-positive and 
contained a similar insulin content than the control 
cells: the hormone content in their culture medium was, 
however, lower suggesting that their secretory activity 
is reduced. These data confirm that intercellular differ- 
ences exist in the /3 cell sensitivity to cytodestructive 
agents [14,15] with a proportion of cells dying and with 
surviving cells that exhibit signs of functional impair- 
ment [16]. 
/3 Cells which survived streptozotocin treatment pre- 
Table I 
Hormone and enzyme content of rat Islet p cells survivmg in vitro 
exposure to streptozotocm* 
Treatment Control Streptozotocm 
Post-treat- - + _ + 
ment culture 
with mcotm- 
amide 2 mM 
Insulin con- 
tent (ng/ng 
DNA) 
Cells 3.8 k 0.7 1.9 f 0.1 562 1.3 4.1 IL 1.4 
Medium 7.0 t 1.2 5.4 f 0.4 1.9 * 0.4* 3.1 f 0.6 
Total 10.8 + 1.8 7 3 t 0.4 7.5 f 1.5 7.8 f 1.7 
GAD activ- 37.4 k 8.7 35.3 + 3.8 2.6 IL 0.8** 8 3 + 1.7*” 
tty (fmoll 
mm/ng 
DNA) 
GDH activ- 3.8 f 0 6 3.1 * 0.3 3.9 * 0.4 2.9 f 0 6 
ity (pmol/ 
min/ng 
DNA) 
*Contents expressed per DNA content m the same sample, contaming 
cells whtch survtved treatment and post-treatment culture. Data are 
means f S E.M., of 4 to 8 independent experiments; statisttcal sigmf- 
rcance of differences IS calculated by paired Student’s f-test: P vs 
control: *P c 0.05, **P < 0 02; Pvs. STZ without nicotm s: 'P < 0.02. 
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sented a similar GDH activity as control cells but their 
GAD activity fell to 10 percent of control values. Their 
signs of functional impairment are thus associated to a 
decline in a cell specific enzyme. This is not necessarily 
an indication for a regulatory role of GAD in the proc- 
ess of glucose-induced insulin release. It may as well 
indicate that surviving cells have lost specific glucose- 
regulated features of differentiated /? cells. Assuming 
that similar cells can occur in vivo following a /? cell 
toxic process, the question arises as to whether they can 
induce autoimmune responses through presentation of 
autoantigens, or, conversely, reduce autoimmune reac- 
tivity by a decline in the expression of cellular autoanti- 
gens such as GAD. The latter mechanism may result in 
a decrease of circulating autoantibodies. however. in the 
presence of surviving p cells. 
Culture of streptozotocin-treated j? cells in the pres- 
ence of nicotinamide reduced the proportion of de- 
stroyed cells as well as the functional impairment of 
surviving cells. The cells that were recovered from this 
condition had maintained a higher rate of hormone 
release and presented also higher GAD levels than those 
collected without nicotinamide. These results extend the 
notion that nicotinamide is partially protectective 
against /I cell damage, even when administered after 
cellular interaction with the damaging agent [13,14]. 
This property may be responsible for a beneficial effect 
of the agent in prediabetic conditions (17). 
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